Concepedia
Statistics
Publications
9
Citations
293
H-Index
Active since
2003
Affiliations
Karolinska Institutet(Current)
Pfizer (Sweden)
Quantify Research (Sweden)
Pfizer (United States)
Uppsala University
Anna De Geer is an author at Karolinska Institutet specializing in oncology, immunology, and medicine.
Publications per year
2003–2023
Autocrine Secretion of Fas Ligand Shields Tumor Cells from Fas-Mediated Killing by Cytotoxic Lymphocytes
Kristian Hallermalm, Anna De Geer, Rolf Kiessling et al. · Cancer Research · 2004 · 80 citations · Full text
Life Sciences, Immunology, Oncology +17
Modulation of the Tumor Cell Phenotype by IFN-γ Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes
Kristian Hallermalm, Kazutake Seki, Anna De Geer et al. · The Journal of Immunology · 2008 · 48 citations · Full text
Medicine, Immunology, Oncology +17
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes
Lena-Maria Carlson, Anna De Geer, Baldur Sveinbjørnsson et al. · OncoImmunology · 2013 · 40 citations · Full text
Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes.
Simona Vertuani, Anna De Geer, Victor Levitsky et al. · PubMed · 2003 · 37 citations
Life Sciences, Immunology, Oncology +16
Cost-effectiveness of Apixaban versus Warfarin and Aspirin in Sweden for Stroke Prevention in Patients with Atrial Fibrillation
Tereza Lanitis, Thitima Kongnakorn, Lena Jacobson et al. · Thrombosis Research · 2014 · 30 citations · Full text
Pharmacy, Pharmacoeconomics, Pharmacotherapy +17
1–5 of 9